Skip to main content
. 2020 Aug 22;9(2):735–744.e6. doi: 10.1016/j.jaip.2020.08.016

Table I.

Study flowchart

Study components Patients with PAD Controls
Screened, n 68 42
Declined or excluded, n (% screened) 24 (of 68 = 35%) 0
Enrolled, n (% screened) 44 (of 68 = 65%) 42
Household pairs enrolled, n (% group) 34 (68 of 86 = 79%)
Baseline questionnaire completion (% total expected)
 22-item Sino-Nasal Outcome Test 43 (of 44 = 98%) 39 (of 42 = 93%)
 St George's Respiratory Questionnaires 43 (of 44 = 98%) 39 (of 42 = 93%)
 Pulmonary function testing 42 (of 44 = 95%) 41 (of 42 = 98%)
Study dropout 7 (of 44 = 16%) 4 (of 42 = 10%)
Total swabs returned, n 870 626
Nasal swabs (2-weekly) compliance (% of total expected) 72% (of 1144 expected) 78% (of 745 expected)
Total daily symptom score data (d) 11,397 11,192
Daily questionnaire compliance (% of total expected) 71% (of 16,016 expected) 73% (of 15,288 expected)

Compliance is shown in parentheses, represented as a % of total expected. For nasal swabs received from controls, this was calculated following protocol amendment.